NLRP3 and atherosclerosis: More recently, in two mouse models of atherosclerosis, Tranilast promoted NLRP3 ubiquitination, limiting NLRP3 inflammasome assembly and thus resulting in a blunted initiation and progression of atherosclerotic plaques [112].